$1.72 Billion is the total value of Eventide Asset Management's 135 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 44.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | CELGENE CORP | $73,404,000 | -4.6% | 678,600 | +2.0% | 4.26% | +2.4% |
| PANW | Buy | PALO ALTO NETWORKS INC | $62,522,000 | +53.7% | 363,500 | +56.1% | 3.63% | +65.0% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $52,064,000 | -0.6% | 697,350 | +10.0% | 3.02% | +6.8% |
| LOW | Buy | LOWES COS INC | $50,339,000 | +16.5% | 730,400 | +13.2% | 2.92% | +25.1% |
| RHT | Buy | RED HAT INC | $48,993,000 | +11.0% | 681,600 | +17.3% | 2.85% | +19.3% |
| LEA | Buy | LEAR CORP | $47,754,000 | +30.0% | 439,000 | +34.1% | 2.78% | +39.6% |
| ABBV | Buy | ABBVIE INC | $44,688,000 | -15.2% | 821,325 | +4.7% | 2.60% | -8.9% |
| LRCX | Buy | LAM RESEARCH CORP | $43,289,000 | +10.3% | 662,625 | +37.4% | 2.52% | +18.5% |
| EXR | Buy | EXTRA SPACE STORAGE INC | $41,682,000 | +59.4% | 540,200 | +34.7% | 2.42% | +71.2% |
| KAR | Buy | KAR AUCTION SVCS INC | $41,553,000 | +17.1% | 1,170,500 | +23.4% | 2.41% | +25.7% |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $41,131,000 | +12.6% | 521,500 | +14.7% | 2.39% | +21.0% |
| MBBYF | Buy | MOBILEYE N V AMSTELVEEN | $39,740,000 | -2.8% | 873,800 | +13.6% | 2.31% | +4.3% |
| CYBR | Buy | CYBERARK SOFTWARE LTD | $39,545,000 | +10.4% | 788,700 | +38.4% | 2.30% | +18.6% |
| BLUE | Buy | BLUEBIRD BIO INC | $35,897,000 | -47.1% | 419,600 | +4.2% | 2.09% | -43.2% |
| QLIK | Buy | QLIK TECHNOLOGIES INC | $35,830,000 | +96.6% | 983,000 | +88.6% | 2.08% | +111.2% |
| SPLK | Buy | SPLUNK INC | $35,059,000 | -11.5% | 633,400 | +11.4% | 2.04% | -4.9% |
| MGA | MAGNA INTL INC | $33,847,000 | -14.4% | 705,000 | 0.0% | 1.97% | -8.1% | |
| SYNA | SYNAPTICS INC | $32,201,000 | -4.9% | 390,500 | 0.0% | 1.87% | +2.1% | |
| WAB | WABTEC CORP | $30,818,000 | -6.6% | 350,000 | 0.0% | 1.79% | +0.3% | |
| PFPT | PROOFPOINT INC | $29,732,000 | -5.3% | 492,900 | 0.0% | 1.73% | +1.8% | |
| DATA | Buy | TABLEAU SOFTWARE INCcl a | $29,726,000 | -24.9% | 372,600 | +8.5% | 1.73% | -19.4% |
| XPO | Buy | XPO LOGISTICS INC | $28,234,000 | -26.3% | 1,184,800 | +39.7% | 1.64% | -20.9% |
| DYAX | Buy | DYAX CORP | $27,686,000 | -21.5% | 1,450,300 | +9.0% | 1.61% | -15.7% |
| ASML | ASML HOLDING N V | $27,511,000 | -15.5% | 312,700 | 0.0% | 1.60% | -9.3% | |
| TSLA | TESLA MTRS INC | $27,399,000 | -7.4% | 110,300 | 0.0% | 1.59% | -0.6% | |
| WBC | WABCO HLDGS INC | $26,795,000 | -15.3% | 255,600 | 0.0% | 1.56% | -9.0% | |
| STLD | Buy | STEEL DYNAMICS INC | $26,036,000 | +3.7% | 1,515,500 | +25.1% | 1.51% | +11.4% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $21,566,000 | +62.1% | 975,418 | +30.8% | 1.25% | +74.0% |
| IDTI | INTEGRATED DEVICE TECHNOLOGY | $20,864,000 | -6.5% | 1,027,800 | 0.0% | 1.21% | +0.4% | |
| CPN | Buy | CALPINE CORP | $20,466,000 | +41.6% | 1,401,800 | +74.4% | 1.19% | +52.0% |
| BWA | Buy | BORGWARNER INC | $20,462,000 | -1.7% | 492,000 | +34.4% | 1.19% | +5.6% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $20,453,000 | +10.8% | 479,900 | +18.4% | 1.19% | +18.9% |
| CMRX | Buy | CHIMERIX INC | $20,418,000 | -10.0% | 534,500 | +8.9% | 1.19% | -3.3% |
| SUNEQ | Buy | SUNEDISON INC | $20,302,000 | -56.9% | 2,827,600 | +79.7% | 1.18% | -53.7% |
| IMPV | Sell | IMPERVA INC | $20,279,000 | -9.1% | 309,700 | -6.1% | 1.18% | -2.5% |
| MDVN | Buy | MEDIVATION INC | $19,865,000 | -16.4% | 467,400 | +124.5% | 1.15% | -10.3% |
| IPHI | INPHI CORP | $19,210,000 | +5.2% | 799,100 | 0.0% | 1.12% | +13.0% | |
| CBI | CHICAGO BRIDGE & IRON CO N V | $18,569,000 | -20.7% | 468,200 | 0.0% | 1.08% | -14.9% | |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $17,928,000 | -24.7% | 1,164,900 | +21.6% | 1.04% | -19.0% |
| TERP | New | TERRAFORM PWR INC | $17,769,000 | – | 1,249,550 | +100.0% | 1.03% | – |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $17,287,000 | -6.4% | 244,900 | +47.4% | 1.00% | +0.5% |
| SCTY | SOLARCITY CORP | $15,922,000 | -20.2% | 372,800 | 0.0% | 0.92% | -14.4% | |
| MGNX | Buy | MACROGENICS INC | $15,200,000 | -35.7% | 709,600 | +14.0% | 0.88% | -31.0% |
| NVAX | Buy | NOVAVAX INC | $14,829,000 | -30.3% | 2,097,500 | +9.9% | 0.86% | -25.1% |
| SPWR | New | SUNPOWER CORP | $12,860,000 | – | 641,700 | +100.0% | 0.75% | – |
| STKL | Buy | SUNOPTA INC | $12,588,000 | -9.1% | 2,590,200 | +100.8% | 0.73% | -2.4% |
| LLTC | LINEAR TECHNOLOGY CORP | $11,806,000 | -8.8% | 292,600 | 0.0% | 0.69% | -2.0% | |
| UFS | Buy | DOMTAR CORP | $11,740,000 | +29.7% | 328,400 | +50.2% | 0.68% | +39.2% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $10,804,000 | -4.8% | 326,700 | +20.5% | 0.63% | +2.3% |
| EOG | EOG RES INC | $10,541,000 | -16.8% | 144,800 | 0.0% | 0.61% | -10.8% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $10,481,000 | +32.9% | 326,400 | +26.0% | 0.61% | +42.6% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $10,161,000 | +18.0% | 105,500 | +25.4% | 0.59% | +26.6% |
| VCYT | Buy | VERACYTE INC | $9,934,000 | -56.5% | 2,118,068 | +3.2% | 0.58% | -53.4% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $9,792,000 | +35.4% | 246,100 | +62.5% | 0.57% | +45.5% |
| LGND | LIGAND PHARMACEUTICALS INC | $9,721,000 | -15.1% | 113,500 | 0.0% | 0.56% | -8.9% | |
| AYR | AIRCASTLE LTD | $8,833,000 | -9.1% | 428,600 | 0.0% | 0.51% | -2.5% | |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $8,595,000 | +124.8% | 241,500 | +88.1% | 0.50% | +141.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,468,000 | +19.5% | 80,400 | +55.2% | 0.49% | +28.5% |
| KITE | New | KITE PHARMA INC | $7,795,000 | – | 140,000 | +100.0% | 0.45% | – |
| ATHN | Buy | ATHENAHEALTH INC | $7,734,000 | +314.0% | 58,000 | +255.8% | 0.45% | +344.6% |
| CGNX | COGNEX CORP | $7,046,000 | -28.5% | 205,000 | 0.0% | 0.41% | -23.4% | |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $6,888,000 | +51.2% | 280,700 | +44.3% | 0.40% | +61.9% |
| SGEN | Buy | SEATTLE GENETICS INC | $6,794,000 | +9.6% | 176,200 | +37.5% | 0.40% | +17.9% |
| TSRO | Buy | TESARO INC | $6,737,000 | -0.7% | 168,000 | +45.6% | 0.39% | +6.5% |
| STML | Buy | STEMLINE THERAPEUTICS INC | $6,490,000 | -21.7% | 735,000 | +4.4% | 0.38% | -16.0% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $6,277,000 | +41.5% | 68,700 | +90.3% | 0.36% | +52.1% |
| ININ | Sell | INTERACTIVE INTELLIGENCE GRO | $6,245,000 | -36.8% | 210,200 | -5.4% | 0.36% | -32.1% |
| CERN | Buy | CERNER CORP | $6,092,000 | +35.1% | 101,600 | +55.6% | 0.35% | +45.1% |
| LOXO | Buy | LOXO ONCOLOGY INC | $5,929,000 | +34.9% | 339,200 | +39.2% | 0.34% | +44.5% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $5,681,000 | +4.2% | 70,700 | +55.4% | 0.33% | +11.9% |
| PWR | QUANTA SVCS INC | $5,636,000 | -16.0% | 232,800 | 0.0% | 0.33% | -9.9% | |
| NTUS | Buy | NATUS MEDICAL INC DEL | $5,365,000 | +68.1% | 136,000 | +81.3% | 0.31% | +80.3% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $5,045,000 | +71.9% | 119,200 | +196.5% | 0.29% | +84.3% |
| RGEN | Buy | REPLIGEN CORP | $4,968,000 | +21.1% | 178,400 | +79.5% | 0.29% | +30.2% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $4,891,000 | +0.5% | 348,600 | +21.6% | 0.28% | +8.0% |
| RTRX | Buy | RETROPHIN INC | $4,875,000 | -10.9% | 240,600 | +45.7% | 0.28% | -4.4% |
| GLBL | New | TERRAFORM GLOBAL INCcl a | $4,531,000 | – | 680,400 | +100.0% | 0.26% | – |
| XNCR | Buy | XENCOR INC | $4,484,000 | -37.7% | 366,600 | +11.9% | 0.26% | -33.1% |
| CMRE | COSTAMARE INC | $4,420,000 | -33.2% | 360,200 | 0.0% | 0.26% | -28.2% | |
| CEMP | Buy | CEMPRA INC | $4,365,000 | -17.4% | 156,800 | +2.0% | 0.25% | -11.2% |
| ATRC | Buy | ATRICURE INC | $4,034,000 | +7.5% | 184,100 | +20.9% | 0.23% | +15.3% |
| PRTA | New | PROTHENA CORP PLC | $3,952,000 | – | 87,172 | +100.0% | 0.23% | – |
| TCON | New | TRACON PHARMACEUTICALS INC | $3,946,000 | – | 403,912 | +100.0% | 0.23% | – |
| TGTX | Buy | TG THERAPEUTICS INC | $3,788,000 | -15.8% | 375,800 | +38.6% | 0.22% | -9.5% |
| CAFD | New | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $3,545,000 | – | 334,100 | +100.0% | 0.21% | – |
| ZSAN | Buy | ZOSANO PHARMA CORP | $3,502,000 | -45.0% | 884,400 | +0.7% | 0.20% | -41.2% |
| CSLT | Buy | CASTLIGHT HEALTH INCcl b | $3,291,000 | -26.6% | 783,600 | +42.3% | 0.19% | -21.4% |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $3,292,000 | +4.4% | 250,500 | +21.9% | 0.19% | +11.7% |
| MCRB | New | SERES THERAPEUTICS INC | $3,187,000 | – | 107,530 | +100.0% | 0.18% | – |
| QURE | Buy | UNIQURE NV | $3,168,000 | +29.6% | 154,900 | +71.2% | 0.18% | +39.4% |
| SGMO | SANGAMO BIOSCIENCES INC | $2,721,000 | -49.1% | 482,500 | 0.0% | 0.16% | -45.5% | |
| INSM | Buy | INSMED INC | $2,685,000 | +24.1% | 144,600 | +63.2% | 0.16% | +33.3% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $2,589,000 | -32.6% | 315,300 | +14.5% | 0.15% | -27.9% |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $2,437,000 | +27.3% | 146,900 | +72.6% | 0.14% | +36.5% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $2,412,000 | -66.9% | 228,800 | -20.7% | 0.14% | -64.5% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,283,000 | – | 107,000 | +100.0% | 0.13% | – |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $2,231,000 | +29.8% | 175,400 | +43.0% | 0.13% | +39.8% |
| XLRN | ACCELERON PHARMA INC | $2,169,000 | -21.3% | 87,100 | 0.0% | 0.13% | -15.4% | |
| ONCE | Buy | SPARK THERAPEUTICS INC | $2,045,000 | -11.2% | 49,000 | +28.3% | 0.12% | -4.8% |
| IMDZ | Buy | IMMUNE DESIGN CORP | $1,885,000 | -11.3% | 154,501 | +50.1% | 0.11% | -4.3% |
| CSII | Buy | CARDIOVASCULAR SYS INC DEL | $1,825,000 | -33.5% | 115,200 | +11.1% | 0.11% | -28.4% |
| ARAY | ACCURAY INC | $1,821,000 | -25.9% | 364,600 | 0.0% | 0.11% | -20.3% | |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $1,665,000 | +35.0% | 197,100 | +75.0% | 0.10% | +44.8% |
| TNDM | TANDEM DIABETES CARE INC | $1,368,000 | -18.7% | 155,300 | 0.0% | 0.08% | -13.2% | |
| TTPH | Sell | TETRAPHASE PHARMACEUTICALS I | $1,298,000 | -90.6% | 174,000 | -40.0% | 0.08% | -89.9% |
| RGLS | REGULUS THERAPEUTICS INC | $1,050,000 | -40.3% | 160,516 | 0.0% | 0.06% | -35.8% | |
| MDSO | MEDIDATA SOLUTIONS INC | $796,000 | -22.5% | 18,900 | 0.0% | 0.05% | -17.9% | |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $653,000 | – | 15,479 | +100.0% | 0.04% | – |
| BBN | New | BLACKROCK TAX MUNICPAL BD TR | $148,000 | – | 7,350 | +100.0% | 0.01% | – |
| BAB | New | POWERSHARES ETF TR IIbuild amer etf | $150,000 | – | 5,111 | +100.0% | 0.01% | – |
| GNMA | New | ISHARES TRgnma bond etf | $161,000 | – | 3,203 | +100.0% | 0.01% | – |
| JCI | New | JOHNSON CTLS INC | $114,000 | – | 2,750 | +100.0% | 0.01% | – |
| BDN | New | BRANDYWINE RLTY TRsh ben int new | $116,000 | – | 9,400 | +100.0% | 0.01% | – |
| HTGC | New | HERCULES TECH GROWTH CAP INC | $113,000 | – | 11,200 | +100.0% | 0.01% | – |
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $117,000 | – | 5,650 | +100.0% | 0.01% | – |
| SEP | New | SPECTRA ENERGY PARTNERS LP | $109,000 | – | 2,700 | +100.0% | 0.01% | – |
| NSC | New | NORFOLK SOUTHERN CORP | $84,000 | – | 1,100 | +100.0% | 0.01% | – |
| ERIC | New | ERICSSONadr b sek 10 | $88,000 | – | 9,000 | +100.0% | 0.01% | – |
| SE | New | SPECTRA ENERGY CORP | $85,000 | – | 3,250 | +100.0% | 0.01% | – |
| ETN | New | EATON CORP PLC | $77,000 | – | 1,500 | +100.0% | 0.00% | – |
| BEP | New | BROOKFIELD RENEWABLE ENRGY Ppartnership unit | $69,000 | – | 2,500 | +100.0% | 0.00% | – |
| SYK | New | STRYKER CORP | $56,000 | – | 600 | +100.0% | 0.00% | – |
| HCP | New | HCP INC | $55,000 | – | 1,470 | +100.0% | 0.00% | – |
| DLR | New | DIGITAL RLTY TR INC | $56,000 | – | 850 | +100.0% | 0.00% | – |
| WBK | New | WESTPAC BKG CORPsponsored adr | $51,000 | – | 2,400 | +100.0% | 0.00% | – |
| LPT | New | LIBERTY PPTY TRsh ben int | $57,000 | – | 1,800 | +100.0% | 0.00% | – |
| NYLD | New | NRG YIELD INCcl c | $59,000 | – | 5,100 | +100.0% | 0.00% | – |
| ABB | New | ABB LTDsponsored adr | $29,000 | – | 1,650 | +100.0% | 0.00% | – |
| PEGI | New | PATTERN ENERGY GROUP INCcl a | $39,000 | – | 2,050 | +100.0% | 0.00% | – |
| NATI | New | NATIONAL INSTRS CORP | $28,000 | – | 1,000 | +100.0% | 0.00% | – |
| LXP | New | LEXINGTON REALTY TRUST | $29,000 | – | 3,550 | +100.0% | 0.00% | – |
| ABY | New | ABENGOA YIELD PLC | $28,000 | – | 1,700 | +100.0% | 0.00% | – |
| AGM | New | FEDERAL AGRIC MTG CORPcl c | $18,000 | – | 700 | +100.0% | 0.00% | – |
| HCN | New | HEALTH CARE REIT INC | $7,000 | – | 100 | +100.0% | 0.00% | – |
| NEP | New | NEXTERA ENERGY PARTNERS LP | $2,000 | – | 100 | +100.0% | 0.00% | – |
| CDXS | Exit | CODEXIS INC | $0 | – | -10,000 | -100.0% | -0.00% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -10,900 | -100.0% | -0.00% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -16,000 | -100.0% | -0.01% | – |
| XOMA | Exit | XOMA CORP DEL | $0 | – | -152,200 | -100.0% | -0.03% | – |
| FEIC | Exit | FEI CO | $0 | – | -14,800 | -100.0% | -0.07% | – |
| SAAS | Exit | INCONTACT INC | $0 | – | -150,000 | -100.0% | -0.08% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -39,000 | -100.0% | -0.17% | – |
| AZPN | Exit | ASPEN TECHNOLOGY INC | $0 | – | -83,000 | -100.0% | -0.20% | – |
| TEX | Exit | TEREX CORP NEW | $0 | – | -557,400 | -100.0% | -0.70% | – |
| NRG | Exit | NRG ENERGY INC | $0 | – | -856,100 | -100.0% | -1.06% | – |
| TRN | Exit | TRINITY INDS INC | $0 | – | -913,100 | -100.0% | -1.31% | – |
| FEYE | Exit | FIREEYE INC | $0 | – | -828,300 | -100.0% | -2.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-13
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.